Clinical and mental health characteristics among patients receiving medications for opioid use disorder treatment versus patients receiving low- and high-dose opioids when referred for pain management - Top-Institutions - MDSpire

Clinical and mental health characteristics among patients receiving medications for opioid use disorder treatment versus patients receiving low- and high-dose opioids when referred for pain management

  • By

  • Jie Yang

  • Melita Giummarra

  • Louisa Picco

  • Carolyn Arnold

  • Suzanne Nielsen

  • February 12, 2025

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Pain Medicine
    • Addiction Psychiatry
    • Behavioral Health

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Pain Research
    • Addiction Medicine
    • Psychiatry

  • #3

    University of Sydney
    University of Sydney

    Sydney, NSW

    Key Differentiators

    • Pain Medicine
    • Addiction Treatment
    • Public Health

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Addiction Medicine
    • Pain Management
    • Psychiatry

  • #5

    University of Queensland
    University of Queensland

    Brisbane, QLD

    Key Differentiators

    • Pain Medicine
    • Addiction Research
    • Mental Health

Original Source(s)

Clinical and mental health characteristics among patients receiving medications for opioid use disorder treatment versus patients receiving low- and high-dose opioids when referred for pain management

  • by Jie Yang, Melita Giummarra, Louisa Picco, Carolyn Arnold, Suzanne Nielsen

  • February 12, 2025

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Development and validation of a machine learning–based risk prediction model for non-suicidal self-injury in adolescents

Psychological inflexibility and resilience in anxiety: insights from machine-learning and robust mediation-based models